Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > It's all about the Clinic
View:
Post by fredgoodwinson on Aug 25, 2022 3:00pm

It's all about the Clinic

Doesen`t seem to be much FOMO about and BMO (or Clients thereof) have been selling heavily since the mid 30`s.

Anyway,we should know soon.
Comment by Rumpl3StiltSkin on Aug 25, 2022 3:34pm
Fred, who is BMO again?
Comment by fredgoodwinson on Aug 25, 2022 3:41pm
Hi Rumpl. Merely a subjective observation devoid of any further implication that BMO (or their Clients) have tended over time to call the top/bottom of particular cycles in TLT trading.
Comment by Rumpl3StiltSkin on Aug 25, 2022 3:57pm
BMO Harris, out of Chicago... Interesting, so I hope you're not sayin' this is a top.... :-)
Comment by fredgoodwinson on Aug 25, 2022 4:06pm
BMO Nesbitt Burns I think Rumpl - right now I ain`t saying anything!
Comment by StevenBirch on Aug 25, 2022 4:53pm
My thinking Fred is if there is a major player or players taking a position in TLT they can do it through different brokers. It just seems like the same 3 or 4 firms going back and forth. So when it looks like someone is selling they can actually be replacing it and probably even adding through another firm. And as long as they don't buy from or sell to themselves it's OK.
Comment by fredgoodwinson on Aug 25, 2022 5:11pm
Yes Steven - this has been a very long game at the expense of retail shareholders.and it is not quite over yet. The OSC and IIROC should hang their heads in shame.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250